RSC Advances
Paper
J ¼ 8.2 Hz, 2H, ArH); 7.83–7.95 (m, 3H, ArH), 8.04 (d, J ¼ 8.4 Hz,
2H, ArH); 13C NMR (100 MHz, CDCl3): d ¼ 28.4, 29.3, 35.7, 91.2,
117.4, 118.3, 124.2, 125.6, 126.7, 128.9, 129.7, 129.9, 131.8,
132.0, 134.1, 143.6, 147.8, 150.8, 151.5, 161.6.
Conclusions
In summary, we have developed an efficient and eco-friendly
approach for the synthesis of naphthopyranopyrimidine deriv-
atives via one-pot three-component reaction of aromatic alde-
hydes, b-naphthol and 6-amino-1,3-dimethyl uracil in the
presence of Al(H2PO4)3 as a catalyst under solvent-free condi-
tions. The important aspects of this protocol are simple
procedure, cleaner reaction and easy workup, use of inexpensive
and reusable catalyst, short reaction times and good to high
yields.
Fig. 3 Recyclability of the catalyst in the synthesis of 4a over 5 runs.
methanol to give the pure product 4. All products are known
and their structures were conrmed by comparison of their
melting points and spectral data (1H and 13C NMR) with liter-
ature.14,15,19,20 Spectral data for selected compounds are pre-
sented below.
Acknowledgements
I gratefully acknowledge nancial support from the Research
Council of the Payame Noor Universitry (PNU).
12-Phenyl-8,12-dihydro-8,10-dimethyl-9H-naphtho[10,20:5,6]
1
pyrano[2,3-d]pyrimidine-9,11-(10H)-dione (4a). White solid; H
NMR (400 MHz, CDCl3): d ¼ 3.37 (s, 3H, CH3), 3.63 (s, 3H, CH3),
5.83 (s, 1H, CH), 7.12–7.50 (m, 8H, ArH), 7.85 (t, J ¼ 8.4 Hz, 2H,
ArH), 7.98 (d, J ¼ 8.0 Hz, 1H, ArH); 13C NMR (100 MHz, CDCl3):
d ¼ 28.3, 29.1, 35.6, 91.8, 116.9, 118.0, 124.3, 125.5, 126.4, 127.9,
128.5, 128.8, 129.1, 130.0, 131.1, 131.8, 143.7, 148.6, 151.1,
152.3, 161.8.
References
1 F. Shirini, P. N. Moghadam, S. Moayedi and M. Seddighi,
RSC Adv., 2014, 4, 38581–38588.
2 F. d'Yvoire, Bull. Soc. Chim. Fr., 1961, 2277.
3 S. K. Bharadwaj, S. Hussain, M. Kar and M. K. Chaudhuri,
Catal. Commun., 2008, 9, 919–923.
4 (a) H. R. Shaterian, M. Ghashang, N. T. Riki and M. Asadi,
Can. J. Chem., 2008, 86, 841–845; (b) H. R. Shaterian,
A. Amirzadeh, F. Khorami and M. Ghashang, Synth.
Commun., 2008, 38, 2983–2994; (c) H. R. Shaterian,
A. Hosseinian and M. Ghashang, Phosphorus, Sulfur Silicon
Relat. Elem., 2009, 184, 126–134.
5 (a) M. T. Maghsoodlou, S. M. Habibi-Khorassani, R. Heydari,
N. Hazeri, S. S. Sajadikhah and M. Rostamizadeh, Chin.
J. Chem., 2010, 28, 285–288; (b) S. S. Sajadikhah, N. Hazeri,
12-(4-Methylphenyl)-8,12-dihydro-8,10-dimethyl-9H-naph-
tho[10,20:5,6]pyrano[2,3-d]pyrimidine-9,11-(10H)-dione
(4b).
1
White solid; H NMR (400 MHz, CDCl3): d ¼ 2.22 (s, 3H, CH3),
3.36 (s, 3H, CH3), 3.65 (s, 3H, CH3), 5.81 (s, 1H, CH), 7.01 (d,
J ¼ 8.0 Hz, 2H, ArH); 7.24 (d, J ¼ 8.2 Hz, 2H, ArH); 7.39–7.50 (m,
3H, ArH), 7.77–7.84 (m, 2H, ArH), 7.96 (d, J ¼ 8.0 Hz, 1H, ArH);
13C NMR (100 MHz, CDCl3): d ¼ 21.4, 28.5, 28.9, 35.8, 91.6,
116.4, 117.5, 124.0, 125.5, 127.6, 128.1, 128.7, 129.3, 129.5,
131.0, 131.9, 136.4, 141.1, 147.4, 150.8, 152.2, 162.1.
12-(3-Chlorophenyl)-8,12-dihydro-8,10-dimethyl-9H-naph-
tho[10,20:5,6]pyrano[2,3-d]pyrimidine-9,11-(10H)-dione
(4g).
M.
T.
Maghsoodlou,
S.
M.
Habibi-Khorassani,
1
White solid; H NMR (400 MHz, CDCl3): d ¼ 3.35 (s, 3H, CH3),
3.64 (s, 3H, CH3), 5.83 (s, 1H, CH), 7.08–7.52 (m, 7H, ArH), 7.80–
7.99 (m, 3H, ArH); 13C NMR (100 MHz, CDCl3): d ¼ 28.3, 29.4,
35.5, 91.1, 116.8, 118.1, 123.5, 126.0, 126.8, 127.3, 127.7, 128.5,
128.9, 129.5, 129.7, 131.0, 131.7, 134.6, 145.2, 147.9, 150.9,
152.5, 161.7.
A. Beigbabaei and A. C. Willis, J. Iran. Chem. Soc., 2013, 10,
863–871.
6 I. Ugi, Adv. Synth. Catal., 1997, 339, 499–516.
7 J. Zhu and H. Bienayme, Multicomponent reactions, Wiley,
Weinheim, 2005.
´
8 K. C. Joshi, R. Jain, K. Sharma, S. K. Bhattacharya and
R. K. Goel, J. Indian Chem. Soc., 1988, 115, 202–204.
9 A. H. Bedair, N. A. El-Hady, M. S. Abd El-Latif, A. H. Fakery
and A. M. El-Agrody, Farmaco, 2000, 55, 708–714.
10 A. M. El-Agrody, M. S. Abd El-Latif, N. A. El-Hady,
A. H. Fakery and A. H. Bedair, Molecules, 2001, 6, 519–527.
11 V. K. Ahluwalia, M. Chopra and R. Chandra, J. Chem. Res.,
Synop., 2000, 162–163.
12 A. H. Bedair, H. A. Emam, N. A. El-Hady, K. A. R. Ahmed and
A. M. El-Agrody, Farmaco, 2001, 56, 965–973.
13 J. Marugan, K. Liu, W. Zheng, R. Eskay, N. Southall,
M. Heilig, J. Inglese and C. Austin, Probe Report, MLPCN-
Grant X01-DA026210-01.
12-(4-Bromophenyl)-8,12-dihydro-8,10-dimethyl-9H-naph-
tho[10,20:5,6]pyrano[2,3-d]pyrimidine-9,11-(10H)-dione
(4j).
1
White solid; H NMR (400 MHz, CDCl3): d ¼ 3.36 (s, 3H, CH3),
3.60 (s, 3H, CH3), 5.88 (s, 1H, CH), 7.21 (d, J ¼ 8.4 Hz, 2H, ArH);
7.27 (d, J ¼ 8.0 Hz, 2H, ArH), 7.38–7.48 (m, 3H, ArH), 7.79–7.95
(m, 3H, ArH); 13C NMR (100 MHz, CDCl3): d ¼ 28.6, 29.4, 36.0,
91.9, 117.0, 117.7, 121.0, 124.8, 125.6, 127.5, 128.8, 129.4, 129.9,
131.2, 131.7, 132.5, 143.3, 147.7, 150.7, 152.2, 161.9.
12-(4-Nitrophenyl)-8,12-dihydro-8,10-dimethyl-9H-naphtho
[10,20:5,6]pyrano[2,3-d]pyrimidine-9,11-(10H)-dione (4m). White
solid; 1H NMR (400 MHz, CDCl3): d ¼ 3.33 (s, 3H, CH3), 3.62 (s,
3H, CH3), 5.93 (s, 1H, CH), 7.42–7.49 (m, 3H, ArH), 7.59 (d,
28042 | RSC Adv., 2015, 5, 28038–28043
This journal is © The Royal Society of Chemistry 2015